Minocycline Prevents IL-6 Increase after Acute Ischemic Stroke
- 15 March 2012
- journal article
- research article
- Published by Springer Nature in Translational Stroke Research
- Vol. 3 (3) , 364-368
Abstract
Higher levels of the inflammatory biomarker interleukin-6 (IL-6) correlate with poor clinical outcome in acute ischemic stroke (AIS). Minocycline (MC) is a known anti-inflammatory agent; thus, the effect of MC on IL-6 in the first 24 h of AIS was investigated to determine potential anti-inflammatory activity. The Minocycline to Improve Neurologic Outcome in Stroke (MINOS) study was a non-randomized dose-escalation (3.0–10.0 mg/kg) trial of IV MC for AIS within 6 h of onset. Plasma IL-6 samples were collected prior to MC treatment at 1, 24, and 72 h and compared to those collected in a separate observational study of blood biomarkers in AIS. IL-6 levels were measured by commercially available ELISA kits. The lower limit of detection for IL-6 was 1 pg/ml. Sixty MINOS subjects and 29 non-MINOS subjects were enrolled, and there was no difference in baseline stroke severity. There was no significant difference in IL-6 level pre-MC treatment at 1, 24, or 72 h. However, the odds of a non-detectable IL-6 at 24 h in MINOS were 8.94 (95% CI 2.62–30.46) compared with non-MINOS subjects. It is likely that even low doses of MC have a potent systemic anti-inflammatory effect in AIS. Whether this results in improved outcome will be tested in a randomized clinical trial.Keywords
This publication has 15 references indexed in Scilit:
- Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic StrokeCerebrovascular Diseases, 2009
- Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic strokeThrombosis and Haemostasis, 2009
- High plasma glutamate concentrations are associated with infarct growth in acute ischemic strokeNeurology, 2008
- Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcomeClinical Biochemistry, 2008
- Inflammatory markers and in-hospital mortality in acute ischaemic strokeAtherosclerosis, 2006
- Chitotriosidase in Patients with Acute Ischemic StrokeEuropean Neurology, 2005
- IL-6: an early marker for outcome in acute ischemic strokeActa Neurologica Scandinavica, 2005
- Possible vascular-bed-specific role of interleukin-6 in young women with a history of myocardial infarction, lacunar cerebral infarction and deep vein thrombosisCytokine, 2004
- An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosisJournal of Neuroimmunology, 2003
- Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemiaProceedings of the National Academy of Sciences, 1998